Tuesday, June 28, 2011

Patent Covers CNVN202 Nanomolecular Cancer Therapy

AUSTIN, Texas -- Convergen LifeSciences Announces Patent Award for Cancer Suppressors. Convergen LifeSciences, Inc. announced today that a United States Patent has been awarded by the U.S. Patent and Trademark Office jointly to The University of Texas System Board of Regents and The Secretary, U.S. Department of Health and Human Services.

Get More details
www.prnewswire.com/news-releases/convergen-lifesciences-announces-patent-award-for-cancer-suppressors-124640503.html

No comments:

Post a Comment